Breaking Into a Saturated Relapsing Remitting Multiple Sclerosis Market: Where Should Developers Focus?
August 01, 2023 12:02 ET
|
Spherix Global Insights
Exton, Pennsylvania, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Despite outward appearances of being a stagnant market, the relapsing remitting multiple sclerosis (RMS) market continues to offer drug...
Tiziana Life Sciences to Proceed with Phase 2 Clinical Trial in Patients with Non-Active Secondary Progressive Multiple Sclerosis (SPMS)
March 28, 2023 07:00 ET
|
Tiziana Life Sciences Ltd.
First Phase 2 trial employing intranasal foralumab for treating inflammatory neurological diseaseTiziana received FDA Type C Meeting Minutes for proposed Phase 2 clinical trial in patients with...
Tiziana Life Sciences Highlighted in Forbes Article
March 17, 2023 07:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, March 17, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
COMMUNITY EDUCATION GROUP RECEIVES 100K GRANT FOR MONKEYPOX CARE THROUGHOUT RURAL APPALACHIA
October 31, 2022 07:11 ET
|
Community Education Group
Charleston, W. Va, Oct. 31, 2022 (GLOBE NEWSWIRE) -- CHARLESTON, W. Va. (October 31, 2022) – The Community Education Group (CEG) received a $50,000 grant from Gilead Sciences and a $50,000 grant...
Clene Reports Second Quarter 2022 Financial Results and Recent Operating Highlights
August 15, 2022 07:00 ET
|
Clene Inc.
Topline results from the Phase 2 VISIONARY-MS clinical trial with CNM-Au8® met the primary and secondary endpoints of Low Contrast Letter Acuity (LCLA) and modified Multiple Sclerosis Functional...
Pasithea Therapeutics Acquires Alpha-5 Integrin, LLC
June 22, 2022 08:00 ET
|
Pasithea
- Alpha-5 is a potentially first-in-class monoclonal antibody for the treatment of amyotrophic lateral sclerosis (ALS) and other neurological diseases -- Expands pipeline across Pasithea's core...
New Gadolinium-Free MRI Contrast Agent Advances Safer Patient Care
June 13, 2022 10:00 ET
|
Reveal Pharmaceuticals
CAMBRIDGE, Mass., June 13, 2022 (GLOBE NEWSWIRE) -- Contrast agents used in MRI scans to improve the clarity of imaging for diagnostic accuracy, accumulate in the brain and body of every patient,...
Multiple Sclerosis: Is Therapeutic Angiogenesis a Treatment or Even a Possible Cure?
November 18, 2020 00:00 ET
|
Zhittya Genesis Medicine Inc
LAS VEGAS, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (Zhittya), a private company, announced that it will give a Webinar broadcast on its potential breakthrough therapy to...
Telehealth Cognitive Rehabilitation Can Be Effective for Multiple Sclerosis
May 11, 2020 08:00 ET
|
Posit Science
SAN FRANCISCO, May 11, 2020 (GLOBE NEWSWIRE) -- An independent review of the scientific literature found that certain telehealth rehabilitation treatments can be effective in addressing cognitive...
Innodem Neurosciences Receives 1 Million Dollars in Funding to Give a Voice to Voiceless Patients
February 19, 2019 15:49 ET
|
Innodem Neurosciences
MONTREAL, Feb. 19, 2019 (GLOBE NEWSWIRE) -- CENTECH’s Innodem Neurosciences, a Montreal-based start-up that spun-out of McGill University’s Montreal Neurological Institute and Hospital (The NEURO)...